TABLE 1.
Baseline Characteristics of Study Participants
| Participants (n = 40) | |
|---|---|
| Age, years | 36 (19–68) |
| Weight, lb | 180 (111–253) |
| BMI, kg/m2 | 27.8 (21.0–47.0) |
| Sex | |
| Male | 19 (47.5) |
| Female | 21 (52.5) |
| Ethnicity | |
| African American | 2 (5) |
| Caucasian | 33 (82.5) |
| Asian | 2 (5) |
| Multiple races reported | 3 (7.5) |
| Reported A1C, % | 7.5 (5.5–9.0) |
| CGM brand | |
| Medtronic | 16 (40) |
| Dexcom | 22(55) |
| FreeStyle Libre | 0 (0) |
| Missing information | 2 (5) |
| CGM use duration | |
| <3 months | 5 (12.5) |
| 3–6 months | 5 (12.5) |
| 6–12 months | 4 (10.0) |
| 1–2 years | 6 (15.0) |
| 2–3 years | 4 (10.0) |
| >3 years | 16 (40.0) |
| Insulin delivery | |
| MDI regimen | 9 (22.5) |
| Insulin pump | 31 (77.5) |
Data are mean (range) or n (%).